908 Devices (MASS) Revenue Growth (1y) (2021 - 2026)

908 Devices (MASS) Revenue Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Abbott Laboratories 183.59 Bn 176.29 Bn 6.27 Bn 7.78%
2 Stryker 129.07 Bn 126.19 Bn 3.81 Bn 2.63%
3 Medtronic 108.58 Bn 99.36 Bn 6.41 Bn 9.86%
4 Boston Scientific 68.64 Bn 67.19 Bn 3.61 Bn 11.58%
5 Edwards Lifesciences 48.38 Bn 44.71 Bn 1.29 Bn 16.70%
6 Dexcom 28.35 Bn 27.23 Bn 750.30 Mn 15.05%
7 GE HealthCare Technologies 28.13 Bn 25.84 Bn 1.98 Bn 7.41%
8 Smith & Nephew 26.90 Bn 26.33 Bn - -
9 Koninklijke Philips 24.27 Bn 21.15 Bn 2.07 Bn 6.08%
10 908 Devices 259.20 Mn 147.46 Mn 6.88 Mn 13.62%

Historic Data

Download Data
DateValue
Mar 31, 2026 13.62%
Dec 31, 2025 21.17%
Sep 30, 2025 -3.54%
Jun 30, 2025 13.72%
Mar 31, 2025 58.68%
Dec 31, 2024 -0.06%
Sep 30, 2024 1.55%
Jun 30, 2024 -5.23%
Mar 31, 2024 -21.77%
Dec 31, 2023 23.26%
Sep 30, 2023 -9.50%
Jun 30, 2023 8.90%
Mar 31, 2023 14.22%
Dec 31, 2022 -26.50%
Sep 30, 2022 25.92%
Jun 30, 2022 34.18%
Mar 31, 2022 49.85%
Dec 31, 2021 177.09%
Sep 30, 2021 107.42%
Jun 30, 2021 -25.62%